Cite
Humoral Immune Responses after an Omicron-Adapted Booster BNT162b2 Vaccination in Patients with Lymphoid Malignancies.
MLA
Heftdal, Line Dam, et al. “Humoral Immune Responses after an Omicron-Adapted Booster BNT162b2 Vaccination in Patients with Lymphoid Malignancies.” Viruses (1999-4915), vol. 16, no. 1, Jan. 2024, p. 11. EBSCOhost, https://doi.org/10.3390/v16010011.
APA
Heftdal, L. D., Hansen, C. B., Hamm, S. R., Pérez-Alós, L., Fogh, K., Pries-Heje, M., Hasselbalch, R. B., Møller, D. L., Gang, A. O., Ostrowski, S. R., Frikke-Schmidt, R., Sørensen, E., Hilsted, L., Bundgaard, H., Garred, P., Iversen, K., Sabin, C., Nielsen, S. D., & Grønbæk, K. (2024). Humoral Immune Responses after an Omicron-Adapted Booster BNT162b2 Vaccination in Patients with Lymphoid Malignancies. Viruses (1999-4915), 16(1), 11. https://doi.org/10.3390/v16010011
Chicago
Heftdal, Line Dam, Cecilie Bo Hansen, Sebastian Rask Hamm, Laura Pérez-Alós, Kamille Fogh, Mia Pries-Heje, Rasmus Bo Hasselbalch, et al. 2024. “Humoral Immune Responses after an Omicron-Adapted Booster BNT162b2 Vaccination in Patients with Lymphoid Malignancies.” Viruses (1999-4915) 16 (1): 11. doi:10.3390/v16010011.